Ka Cheng

(Former)

1 - 5 out of 5Page size: 10

Publications

  1. 2020
  2. E-pub ahead of print

    Development and validation of a prediction model for airflow obstruction in older Chinese: Guangzhou Biobank Cohort Study

    Peymane Adab, Ka Cheng, G Neil Thomas, 25 Sep 2020, In: Respiratory Medicine. 173, p. 106158

    Research output: Contribution to journal › Article › peer-review

  3. 2014
  4. Published

    Re: Defining Progression in Nonmuscle Invasive Bladder Cancer: It is Time for a New, Standard Definition: D. Lamm, R. Persad, M. Brausi, R. Buckley, J. A. Witjes, J. Palou, A. Böhle, A. M. Kamat, M. Colombel and M. Soloway J Urol 2014;191:20-27

    Rik Bryan, Ka Cheng, Jun 2014, In: International Journal of Urology. 191, 6, p. 1930-1

    Research output: Contribution to journal › Letter › peer-review

  5. Published

    Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential

    Rik Bryan, Neil Shimwell, Wenbin Wei, Adam Devall, Sarah Pirrie, Nicholas James, Maurice Zeegers, Ka Cheng, Ashley Martin & Douglas Ward, 4 Feb 2014, In: British Journal of Cancer. 110, 3, p. 679-85 7 p.

    Research output: Contribution to journal › Article › peer-review

  6. 2013
  7. Published

    Expression of Engrailed-2 (EN2) protein in bladder cancer and its potential utility as a urinary diagnostic biomarker

    Rik Bryan, Maurice Zeegers, Ka Cheng, Nicholas James, Douglas Ward, 21 Feb 2013, In: European Journal of Cancer .

    Research output: Contribution to journal › Article › peer-review

  8. 2009
  9. Published

    Re: Palou et al.: Recurrence at three months and high-grade recurrence as prognostic factor of progression in multivariate analysis of T1G2 bladder tumors. (Urology 2009;73:1313-1317)

    Rik Bryan, Ka Cheng, 2009, In: Urology. 74, 3, p. 714

    Research output: Contribution to journal › Letter › peer-review